Plasma levels of copeptin in patients with coronary heart disease

Heart and Vessels

Volumn 24, Issue 2, 2009, Pages 79-83

  Chai, San Bao ^a   Hui, Yong Ming ^a   Li, Xue Min ^b   Xiao, Yang ^c   Tang, Chao Shu ^c  

^a Huaishuling Branch of Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^b PEKING UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Arginine vasopressin; Copeptin; Coronary heart disease; Percutaneous transluminal coronary angioplasty

Indexed keywords

COPEPTIN; GLYCOPEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; EARLY INTERVENTION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RISK FACTOR; STATISTICAL ANALYSIS; STUDENT T TEST; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; STENTS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 64249085100     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-008-1086-1     Document Type: Article

References (26)

1. Robertson GL (2001) Antidiuretic hormone. Normal and disordered function. Endocrinol Metab Clin North Am 30:671-694, vii
2. Singh Ranger G (2002) The physiology and emerging roles of antidiuretic hormone. Int J Clin Pract 56:777-782
3. LeJemtel TH, Serrano C (2007) Vasopressin dysregulation: Hyponatremia, fluid retention and congestive heart failure. Int J Cardiol 120:1-9
4. Schäfer U, Kurz T, Jain D, Hartmann F, Dendorfer A, Tölg R, Raasch W, Dominiak P, Katus H, Richardt G (2002) Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: Role of neurohumoral activation? Basic Res Cardiol 97:399-408
5. Robertson GL, Mahr EA, Athar S, Sinha T (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52:2340-2352
6. Holwerda DA (1972) A glycopeptin from the posterior lobe of pig pituitaries. I. Isolation and characterization. Eur J Biochem 28:334-339
7. Smyth DG, Massey DE (1979) A new glycopeptide in pig, ox, and sheep pituitary. Biochem Biophys Res Commun 87:1006-1010
8. Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500-2504
9. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:1112-1119
10. Morgenthaler NG, Müller B, Struck J, Bergmann A, Redl H, Christ-Crain M (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28:219-226
11. Jochberger S, Luckner G, Mayr VD, Wenzel V, Morgenthaler NG, Friesenecker BE, Hasibeder WR, Dünser MW (2006) Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock. Anaesth Intensive Care 34:498-500
12. Khan SQ, Dhillon OS, O'Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Sguire IB, Davies JE, Bergmann A, Nq LL (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115:2103-2110
13. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, Bingisser R, Müller C, Struck J, Müller B, Tamm M (2007) Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 131:1058-1067
14. Stoiser B, Mörtl D, Hülsmann M, Berger R, Struck J, Morgenthaler NG, Bergmann A, Pacher R (2006) Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 36:771-778
15. Gegenhuber A, Struck J, Dieplinger B, Poelz R, Morgenthaler NG, Bergmann A, Bergmann A, Haltmayer M, Mueller T (2007) Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13:42-49
16. Antoniades C, Tousoulis D, Marinou K, Papageorgiou N, Bosinakou E, Tsioufis C, Stefanadi E, Latsios G, Tentolouris C, Siasos G, Stefanadis C (2007) Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis. Clin Cardiol 30:295-300
17. Strickland OL, Giger JN, Nelson MA, Davis CM (2007) The relationships among stress, coping, social support, and weight class in premenopausal African American women at risk for coronary heart disease. J Cardiovasc Nurs 22:272-278
18. Watanabe I, Tani S, Nagao K, Anazawa T, Kawamata H, Ohguchi S, Kanmatsase K, Kushiro T (2005) Regulation of arginine vasopressin in the human heart. Circ J 69:1401-1404
19. Nakamura T, Funayama H, Yoshimura A, Tsuruya Y, Saito M, Kawakami M, Ishikawa SE (2006) Possible vascular role of increased plasma arginine vasopressin in congestive heart failure. Int J Cardiol 106:191-195
20. Maekawa K, Tsujino T, Saito K, Kim JI, Ikeda Y, Emoto N, Yokoyama M (2006) Inhibitory effect of insulin on vasopressininduced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition. Heart Vessels 21:205-212
21. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
22. Hupf H, Grimm D, Riegger GA, Schunkert H (1999) Evidence for a vasopressin system in the rat heart. Circ Res 29:35-41
23. Gregorini L, Marco J, Kozakova M, Palombo C, Anguissola GB, Marco I, Bernies M, Cassagneau B, Distante A, Bossi IM, Fajadet J, Heusch G (1999) α-Adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation 99:482-490
24. Malliani A, Schwartz PJ, Zanchetti A (1969) A sympathetic reflex elicited by experimental coronary occlusion. Am J Physiol 217:703-709
25. Murasaki S, Murasaki K, Tanoue K, Kawana M, Hagiwara N, Kasanuki H (2007) Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina. Heart Vessels 22:376-382
26. Guven M, Guven GS, Oz E, Ozaydin A, Batar B, Ulutin T, Hacihanefioglu S, Domanic N (2007) DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels 22:355-360